EpiPen Gets First Generic Rival After Furor Over High Price (2).

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Abstract:
      FDA clears Teva to sell a copycat of the life-saving device Unlike Mylan's one-cap EpiPen, Teva's proposed generic substitute had two caps, including a removable one that covers the spot where its needle extends. [Extracted from the article]
    • Abstract:
      Copyright of Bloomberg.com is the property of Bloomberg, L.P. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)